Smith & Nephew plc (LON:SN) Insider Purchases £41,948.10 in Stock

Smith & Nephew plc (LON:SN) insider Sybella Stanley acquired 3,810 shares of the firm’s stock in a transaction on Wednesday, March 26th. The stock was purchased at an average cost of GBX 1,101 ($14.25) per share, for a total transaction of £41,948.10 ($54,308.78).

Smith & Nephew Trading Up 0.6 %

Shares of SN stock opened at GBX 1,100 ($14.24) on Friday. The company has a 50-day moving average of GBX 1,069.20 and a 200 day moving average of GBX 1,053.48. The company has a current ratio of 2.51, a quick ratio of 0.84 and a debt-to-equity ratio of 70.22. The company has a market capitalization of £12.06 billion, a PE ratio of 39.60, a P/E/G ratio of 0.46 and a beta of 0.62.

Smith & Nephew Increases Dividend

The business also recently announced a dividend, which will be paid on Wednesday, May 28th. Stockholders of record on Thursday, March 27th will be issued a dividend of $0.23 per share. This is a positive change from Smith & Nephew’s previous dividend of $0.14. This represents a dividend yield of 1.61%. The ex-dividend date of this dividend is Thursday, March 27th. Smith & Nephew’s dividend payout ratio is 104.41%.

Analysts Set New Price Targets

Separately, JPMorgan Chase & Co. restated an “overweight” rating and issued a GBX 1,180 ($15.28) price target on shares of Smith & Nephew in a research note on Tuesday, January 14th.

Smith & Nephew Company Profile

Smith & Nephew plc, together with its subsidiaries, develops, manufactures, markets, and sells medical devices and services in the United Kingdom and internationally. It operates through three segments: Orthopaedics, Sports Medicine & ENT, and Advanced Wound Management. The company offers knee implant products for knee replacement procedures; hip implants for revision procedures; trauma and extremities products that include internal and external devices used in the stabilization of severe fractures and deformity correction procedures; and other reconstruction products.